Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CV Sciences ( (CVSI) ) has issued an update.
On June 2, 2025, CV Sciences, Inc. held its 2025 Annual Meeting virtually, with approximately 54.6% of the outstanding shares represented by proxy. During the meeting, stockholders elected three directors, ratified the selection of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, approved the executive officer compensation on a non-binding advisory basis, and decided that the advisory vote on executive compensation should occur every two years.
Spark’s Take on CVSI Stock
According to Spark, TipRanks’ AI Analyst, CVSI is a Underperform.
The overall stock score is primarily impacted by significant financial challenges and weak technical indicators. Although there are positive strategic initiatives and efforts to improve profitability, these are currently overshadowed by declining revenues, operational inefficiencies, and valuation concerns.
To see Spark’s full report on CVSI stock, click here.
More about CV Sciences
Average Trading Volume: 225,075
Technical Sentiment Signal: Sell
Current Market Cap: $4.94M
Find detailed analytics on CVSI stock on TipRanks’ Stock Analysis page.